Medical College of Wisconsin Observational Study for Patients Receiving Cancer-Related Care Including Data and Biospecimen Collection for Research

What this Trial Is About

Researchers are conducting an observational study at the Medical College of Wisconsin Cancer Center to collect and analyze data from patients receiving cancer-related treatments. This master protocol supports both retrospective and prospective data collection, including biospecimen sampling, to advance research on individualized cancer therapy. The study uses advanced technologies like machine learning and artificial intelligence to analyze patient data and biological samples for better understanding of cancer treatment responses. This study is non-therapeutic and involves gathering patient data from past and current medical records, as well as collecting new samples of blood, stool, or urine when relevant. These specimens may be analyzed using various scientific techniques to discover biomarkers and investigate molecular and treatment-related features. Participation involves consenting to data and specimen collection during routine cancer care. Participants will provide data that researchers will analyze to observe the number of patients receiving precision cancer therapies and those who do not, alongside their biospecimen contributions over one year. The study aims to minimize burden by combining multiple low-risk research projects under one protocol. Participants can expect routine medical care alongside observational assessments, with no study treatments administered as part of this research.

MCW Master Predict (Profile Related Evidence Determining Individualized Cancer Therapy)